
He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode 41: Forbion's Nanna Lüneborg

Episode 40: GV's Krishna Yeshwant

Episode 39: SV Health Investors' Kate Bingham

Episode 38: Deerfield Management's Jason Fuller
Free AI-powered recaps of BioVenture VoiCes with Chris Garabedian and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.